Ye Xiaoweis research (Ye et al., 2023) points out that wearable technology devices like smartwatches can assess cardiorespiratory health status and quantify maximum oxygen consumption (VO 2 max), which are helpful in predicting AMS
P., Gordon-Larsen, P., Lavie, C
The SUSTAIN-1 phase 3 trial demonstrated the safety and tolerability of once-weekly semaglutide injection as monotherapy in patients with type 2 diabetes, achieving reduction in HbA1c of 1.55% at the highest dose of semaglutide, 1 mg vs
Better Sleep Quality: While not a direct sleep aid, by improving overall energy metabolism and nervous system function, B12 can indirectly contribute to more regulated sleep patterns and improved sleep quality for some individuals
Emerging research on melanocortin-4 receptor (MC4R) agonists combined with GLP-1/GIP agonists has shown promise for enhanced weight loss and prevention of weight regain, potentially addressing the needs of patients who plateau on current monotherapy [53]